Published in J Am Soc Nephrol on October 09, 2015
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. J Am Heart Assoc (2017) 0.76
Dialysis Vascular Access Intervention and the Search for Biomarkers. J Am Soc Nephrol (2015) 0.75
Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access. Toxins (Basel) (2017) 0.75
The gut-kidney axis. Pediatr Nephrol (2016) 0.75
The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models. Toxins (Basel) (2017) 0.75
Clinical practice guidelines for vascular access. Am J Kidney Dis (2006) 6.71
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med (2002) 4.25
Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol (2009) 2.89
Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol (2006) 2.74
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int (2006) 2.64
Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol (2010) 2.16
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant (2009) 2.06
NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis (1997) 1.88
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int (2004) 1.83
Thrombosis in end-stage renal disease. Semin Dial (2003) 1.71
Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation (2012) 1.70
Vascular access for hemodialysis. Kidney Int (1999) 1.65
A bench to bedside view of uremic toxins. J Am Soc Nephrol (2008) 1.63
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost (2007) 1.62
Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis. Eur Heart J (2010) 1.56
Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol (2003) 1.44
Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol (2002) 1.34
Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int (2006) 1.32
The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol (2014) 1.29
Uremia causes endothelial progenitor cell deficiency. Kidney Int (2004) 1.27
Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med (2003) 1.23
Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant (2010) 1.23
Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int (2005) 1.19
Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol (2003) 1.18
Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol (2013) 1.15
Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int (2013) 1.15
Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure. Kidney Int Suppl (1997) 1.12
Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study. Nephrol Dial Transplant (2011) 1.10
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07
Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol (2005) 1.05
Diabetes mellitus and thrombosis. Thromb Res (2011) 1.04
Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. Kidney Int (2001) 1.02
Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg (2003) 1.02
In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin. Angiogenesis (2013) 1.01
Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med (2013) 1.01
Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients. Am J Kidney Dis (2001) 1.00
Tissue factor coagulation pathway and blood cells activation state in renal insufficiency. Hematol J (2001) 0.99
C-reactive protein predicts vascular access thrombosis in hemodialysis patients. Blood Purif (2006) 0.95
Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg (1999) 0.94
Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation. Am J Kidney Dis (2003) 0.89
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J (2009) 0.86
Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol (2008) 0.85
Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS One (2014) 0.84
Predictors of patency after balloon angioplasty in hemodialysis fistulas: a systematic review. J Vasc Interv Radiol (2014) 0.83
The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access. PLoS One (2014) 0.82
Hypercoagulopathy in a hemodialysis patient: are elevations in factors VII and VIII effective? Nephron (1999) 0.82
Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy. Thromb Haemost (2004) 0.81
Venous and arterial thrombosis in dialysis patients. Thromb Haemost (2011) 0.80
Factors associated with patency following angioplasty of hemodialysis fistulae. J Vasc Interv Radiol (2014) 0.79